Abstract Details
|
Hailey Brigger
PRESENTER |
Ms. Brigger has nothing to disclose. |
| Ian P. Johnson | Mr. Johnson has nothing to disclose. |
| Annabelle Shanks, BS | Ms. Shanks has nothing to disclose. |
| Steph Maynez | Ms. Maynez has nothing to disclose. |
| Alison Champagne | Mrs. Champagne has nothing to disclose. |
| Cyprien Rivier, MD (Yale University) | Dr. Rivier has nothing to disclose. |
| Jennifer Johnson, NP | Mrs. Johnson has nothing to disclose. |
| Matt De Both | Mr. De Both has nothing to disclose. |
| Danielle Metz, CCRP | Ms. Metz has nothing to disclose. |
| Darian Chambers, Clinical Research Coordinator | Mr. Chambers has nothing to disclose. |
| Calla Price | Ms. Price has received personal compensation for serving as an employee of TGen. |
| Yareli Barraza | Miss Barraza has nothing to disclose. |
| Sarah Moore | Ms. Moore has nothing to disclose. |
| Ignazio Piras, PhD | Mr. Piras has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. |
| Shaily Agrawal, MBBS | Dr. Agrawal has nothing to disclose. |
| Jua Iglesias Gonzalez (Martinos Center for Biomedical Imaging) | Jua Iglesias Gonzalez has nothing to disclose. |
| Annabel Sorby-Adams (Massachusetts General Hospital and Harvard Medical School) | Annabel Sorby-Adams has nothing to disclose. |
| W. T. Kimberly, MD, PhD (Massachusetts General Hospital) | Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Kimberly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. The institution of Dr. Kimberly has received research support from Alzheimer's Association. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care. |
| Adam De Havenon, MD, FAAN (Yale University) | Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care. |
| Matthew Huentelman (TGen) | Matthew Huentelman has nothing to disclose. |
| Kevin N. Sheth, MD, FAAN (Yale UniversityDivision of Neuro and Critical Care) | Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care. |